FOLD Q1 Earnings and Sales Miss Estimates, Stock Falls

Amicus Therapeutics (FOLD) reported first-quarter 2025 adjusted earnings of 3 cents per share, which missed the Zacks Consensus Estimate of 8 cents. The company had reported a loss of 2 cents per share in the year-ago quarter.(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Revenues totaled $125.2 million, up 13$136 million. The top line comprised sales of ...